Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:5 Issue:4 Number:5 ISSN#:2564-2537
RCT
ACE Report #8507
Ace Report Cover Spine

Use of platelet-rich plasma for treatment of symptomatic degenerative lumbar disease


How to Cite

OrthoEvidence. Use of platelet-rich plasma for treatment of symptomatic degenerative lumbar disease. ACE Report. 2016;5(4):5. Available from: https://myorthoevidence.com/AceReport/Report/8507

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Lumbar intradiskal platelet-rich plasma (PRP) injections: a prospective, double-blind, randomized controlled study

PM R. 2016 Jan;8(1):1-10

Contributing Authors: YA Tuakli-Wosornu A Terry K Boachie-Adjei JR Harrison CK Gribbin EE LaSalle JT Nguyen JL Soloman GE Lutz

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

58 patients with low back pain due to degenerative lumbar disease were randomized to intradiscal injection of 1-2mL of either platelet-rich plasma (PRP) or contrast agent (Omnipaque 180). The purpose of this study was to evaluate the efficacy of PRP for improvement of measures of pain and function relative to a nonactive injection. Follow-up was performed over 8 weeks post-injection. Results after...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE
For Reprints and Permissions, click here

Please Login or Join to leave comments.